Liver cancer

Liver cancer is the fifth most common cancer in men and the ninth in women, over 800.000 of new liver cancer cases were diagnosed during 2018.

Liver cancer is the second-leading cause of cancer death in men and the sixth-leading cause among women.

Showing 1–9 of 86 results

EpiMelt MLH1 test assay

Homo sapiens mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), NM_000249

DNA Methylation Assay Kit for MLH1 based on MS-HRM. Includes controls

EpiMelt CDH1 test assay

Homo sapiens cadherin 1, type 1, E-cadherin (epithelial) (CDH1), NM_004360

DNA Methylation Assay Kit for CDH1, based on MS-HRM. Includes controls

 

EpiMelt CDH13 test assay

Homo sapiens cadherin 13, H-cadherin (heart) (CDH13), NM_001220492

DNA Methylation Assay Kit for CDH13, based on MS-HRM. Includes controls

 

EpiMelt TIMP3 test assay

Homo sapiens TIMP metallopeptidase inhibitor 3 (TIMP3), NM_000362

DNA Methylation Assay Kit for TIMP3, based on MS-HRM. Includes controls

 

EpiMelt GSTP1 test assay

Homo sapiens glutathione S-transferase pi 1 (GSTP1), NM_000852

DNA Methylation Assay Kit for GSTP1, based on MS-HRM. Includes controls

 

EpiMelt DAPK1 test assay

Homo sapiens death-associated protein kinase 1 (DAPK1), NM_004938

DNA Methylation Assay Kit for DAPK1, based on MS-HRM. Includes controls